Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination

Recent Developments in Non–HPV-related Adenocarcinomas of the Lower Female Genital Tract and Their Precursors

(2016) W. Glenn McCluggage   ADVANCES IN ANATOMIC PATHOLOGY

Gardasil-9: A global survey of projected efficacy

(2016) Lukai Zhai et al.   ANTIVIRAL RESEARCH

Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis

(2016) Anne Hammer et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study

(2015) Katsiaryna Holl et al.   INTERNATIONAL JOURNAL OF CANCER

US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

(2015) Mona Saraiya et al.   JNCI-Journal of the National Cancer Institute

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions

(2015) Alyssa M Cornall et al.   BMJ Open

US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

(2015) Mona Saraiya et al.   JNCI-Journal of the National Cancer Institute

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

(2014) E. A. Joura et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Prevalence of Human Papillomavirus Types in Invasive Cervical Cancers From 7 US Cancer Registries Before Vaccine Introduction

(2014) Claudia Hopenhayn et al.   Journal of Lower Genital Tract Disease

Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer

(2014) Gordana Halec et al.   JOURNAL OF PATHOLOGY

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

(2014) Sepehr N Tabrizi et al.   LANCET INFECTIOUS DISEASES

How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions

(2014) Emma T. Callegari et al.   VACCINE

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination

(2013) Jeanne M Pimenta et al.   BMC CANCER

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

(2013) Dorota M Gertig et al.   BMC Medicine

Age-Specific Occurrence of HPV16- and HPV18-Related Cervical Cancer

(2013) S. de Sanjose et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types

(2013) Núria Guimerà et al.   HISTOPATHOLOGY

Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with “low-risk” HPV genotypes 6 and 11

(2013) Alyssa M. Cornall et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey

(2013) Julia M.L. Brotherton et al.   VACCINE

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

(2013) H. Ali et al.   BMJ-British Medical Journal

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

(2012) S. N. Tabrizi et al.   JOURNAL OF INFECTIOUS DISEASES

Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer

(2012) Daan Geraets et al.   JOURNAL OF PATHOLOGY

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

(2012) Beatriz Serrano et al.   Infectious Agents and Cancer

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

(2011) Suzanne M Garland et al.   BMC Medicine

One virus, one lesion-individual components of CIN lesions contain a specific HPV type

(2011) Wim Quint et al.   JOURNAL OF PATHOLOGY

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

(2011) Julia ML Brotherton et al.   LANCET

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia

(2011) Dorota M. Gertig et al.   Sexual Health

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

(2010) Basil Donovan et al.   LANCET INFECTIOUS DISEASES

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

(2009) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States

(2008) R. P. Insinga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

How much cervical cancer in Australia is vaccine preventable? A meta-analysis

(2007) Julia M.L. Brotherton   VACCINE